Pulmonary Embolism
📧 Sign up to get email alerts when something new happens for Pulmonary Embolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-18Clinical Trial Update: Effect of iNO in Patients With Submassive and Massive PE [Phase 2]
A Phase 2 trial evaluating inhaled nitric oxide for submassive and massive pulmonary embolism has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-03-18Clinical Trial Update: Non-Invasive Measurement of Cardiac Output and Stroke Volume in PE [NA]
The clinical trial evaluating non-invasive measurement of cardiac output and stroke volume in pulmonary embolism has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-01-23Clinical Trial Update: Artificial Intelligence to StrategiCally Enhance Pulmonary Embolism Response Team Activation [NA]
A clinical trial evaluating artificial intelligence to strategically enhance Pulmonary Embolism Response Team activation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-15Clinical Trial Update: Exercise Intolerance and Skeletal Muscle Bioenergetics in Children With Deep Venous Thrombosis [NA]
A pediatric clinical trial investigating exercise intolerance and skeletal muscle bioenergetics in children with deep vein thrombosis and pu…
-
CLINICAL_TRIALS withdrawal · 2024-11-13Clinical Trial Update: Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm
The trial evaluating the XAPPORT decision-support app for managing anticoagulation in patients treated with rivaroxaban undergoing elective …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-07-22Clinical Trial Update: Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
A clinical trial evaluating whether epicardial adipose tissue can predict pulmonary embolism and death in patients with lung cancer has been…
-
CLINICAL_TRIALS withdrawal · 2024-03-08Clinical Trial Update: Macitentan to Prevent PRVO [Phase 3]
A Phase 3 trial evaluating macitentan to prevent pulmonary vascular events has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-02-08Clinical Trial Update: Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism [Phase 3]
A Phase 3 trial evaluating half-dose alteplase added to heparin for moderate pulmonary embolism was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-10-08Clinical Trial Update: Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study [Phase 4]
A Phase 4 randomized trial evaluating enoxaparin versus placebo for preventing venous thromboembolism in low-risk cancer patients after surg…
-
CLINICAL_TRIALS withdrawal · 2020-02-17Clinical Trial Update: Use of Gadolinium in CT Pulmonary Angiography [Phase 4]
A Phase 4 clinical trial investigating gadolinium use in CT pulmonary angiography has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-31Clinical Trial Update: Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients [Phase 4]
The Phase 4 trial evaluating the safety of topical tranexamic acid in high-risk total joint arthroplasty patients was withdrawn. The safety …
-
CLINICAL_TRIALS withdrawal · 2017-05-12Clinical Trial Update: Outcomes Study in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip Arthroplasty [Phase 4]
Phase 4 clinical trial evaluating aspirin with mechanical compression devices versus aspirin alone after knee and hip arthroplasty was withd…
-
CLINICAL_TRIALS withdrawal · 2017-01-27Clinical Trial Update: Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux
The trial evaluating outpatient management of stable acute pulmonary embolism using fondaparinux (Arixtra) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-12-16Clinical Trial Update: Inter-Observer Reliability and Accuracy of Tricuspid Annular Plane Systolic Excursion in Patients With Suspected PE in the ED
The clinical trial evaluating inter-observer reliability and accuracy of TAPSE for suspected pulmonary embolism in the emergency department …
-
CLINICAL_TRIALS withdrawal · 2016-11-08Clinical Trial Update: Efficacy of Low (30ml) Versus Full Dose (100ml) Contrast CT Pulmonary Angiography in Detecting Emboli [NA]
The clinical trial comparing low-dose (30 ml) versus full-dose (100 ml) contrast CT pulmonary angiography for detecting pulmonary emboli has…
-
CLINICAL_TRIALS withdrawal · 2016-06-22Clinical Trial Update: Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients
A multicenter registry study evaluating comparative effectiveness of venous thromboembolism management in trauma patients has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2016-04-22Clinical Trial Update: Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
This study evaluating the Crux Vena Cava Filter System was withdrawn; no study results have been reported.
-
CLINICAL_TRIALS withdrawal · 2015-08-13Clinical Trial Update: Evaluation of Lung Doppler Signals in Patients Presenting to EMD
A clinical trial evaluating lung Doppler signals in patients presenting with acute cardiovascular conditions and pneumonia has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2014-03-20Clinical Trial Update: Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II [Phase 3]
A Phase 3 trial evaluating prolongation of the interval between prothrombin time tests in stable patients with atrial fibrillation and valvu…
-
CLINICAL_TRIALS withdrawal · 2013-05-30Clinical Trial Update: Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy [Phase 4]
A Phase 4 clinical trial evaluating fondaparinux for treating pulmonary embolism has been withdrawn. The study aimed to assess whether fonda…
-
CLINICAL_TRIALS withdrawal · 2010-12-10Clinical Trial Update: Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis [Phase 3]
A Phase 3 trial investigating rosuvastatin for prevention of thrombosis in patients with prior venous thrombosis and pulmonary embolism has …
-
EMA withdrawal · 2008-05-16EMA Withdrawn: Quixidar (fondaparinux sodium) — Glaxo Group Ltd.
The EMA indicates withdrawal of Quixidar (fondaparinux sodium) from the market by Glaxo Group Ltd., covering indications including venous th…